US$ 20.83
glp 1 agonist schizophrenia GLP-1 Receptor Agonists Improve Metabolic Outcomes in Patients on Antipsychotics: JAMA GLP-1 agonist semaglutide reduced diabetes
Description
Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release
85 , 89 Further prospective studies are needed to clarify perioperative risks associated with GLP-1 RA use and inform individualized management

In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have been used to control blood glucose levels in patients with diabetes
Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors

doi: 10.1152/ajpgi.00035.2013 116 PostS
Diabetes Care, 48 (7), e93e93
